Entecavir E8

Entecavir E8

Entecavir E8

Min.Order / FOB Price:Get Latest Price

10 Kilogram

Negotiable

  • Min.Order :10 Kilogram
  • Purity: 99% min
  • Payment Terms : L/C,T/T,Other

Keywords

CAS 142217-81-0 99% min C26H27N5O3 supplier in China CAS 142217-81-0 manufacturer

Quick Details

  • Appearance:
  • Application:Used as Pharmaceutical Intermediates,ect.
  • PackAge:as per your request
  • ProductionCapacity:10|Metric Ton|Month
  • Storage:Handle with care; No breakage and leakage
  • Transportation:as per your request

Superiority:

Superior quality, moderate price & quick delivery.

Details:

 

Product Name:

2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one

Synonyms:

(1S,3R,4S)-2-amino-9-[4-(benzyloxy)-3-(benzyloxymethyl)-2-methylidene-cyclopentyl]-3H-purin-6-one; Entecavir intermediate N8; 10-Oxy Iminostilbene Carbonyl Chloride; Entecavir intermediate N-1 ; 2-amino-9-{(1S,3R,4S)-4-(benzyloxy)-3-[(benzyloxy)methyl]-2-methylidenecyclopentyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-((1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-9H-purin-6-ol; The intermediate of Entecavir hydrate; (1S,3R,4S)-2-amino-9-[4-(benzyloxy)-3-(benzyloxymethyl)- 2-methylidene-cyclopentyl]-6H-purin-6-one; 2-amino-9-((1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclophentyl)-1H-purin-6(9H)-one; Entecavir intermediate 8; Intermediate of Entecavir 4; 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-

CAS RN.:

142217-81-0

EINECS: Add
Molecular Weight: 457.5243
Molecular Formula: C26H27N5O3
Density: 1.34g/cm3
refractive_index: 1.679

 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View